Counterforce Health Team

The Critical Challenge Facing Neurology Practices Today Neurology clinics across the United States face an unprecedented crisis in healthcare delivery. With over 1 billion people worldwide affected by neurological disorders, neurologists are overwhelmed by administrative tasks that consume up to 16 hours per week—time that should be devoted to

Rheumatology practices face an existential financial challenge in 2025: escalating denial rates for high-value biologic medications that represent the cornerstone of modern inflammatory disease treatment. With biologic therapies accounting for 60-70% of rheumatology practice revenue and denial rates climbing to 25-35% for specialty medications, clinics are hemorrhaging millions in recoverable

Neurology clinics face a mounting financial and clinical crisis that threatens both patient outcomes and practice viability: step-therapy requirements that delay critical treatments while simultaneously devastating revenue cycles. In 2025, neurological practices report that 35-45% of their prescription denials stem from step-therapy protocols, where insurers mandate patients try—and fail—

Oncology practices face unprecedented financial pressure in 2025. With claim denial rates averaging 12-15% across healthcare and climbing as high as 20% for specialty practices, cancer care providers are hemorrhaging revenue at alarming rates. The American Medical Association reports that practices spend an average of $8.6 billion annually fighting

The Silent Crisis in Psychiatry: Why Traditional RCM Fails Your Practice and Your Patients Psychiatry practices face a unique and often overwhelming set of challenges in Revenue Cycle Management (RCM). It's not just about managing appointments; it's about navigating complex time-based codes, frequent telehealth modifiers, and

Why Counterforce Health Dominates Clinic RCM in 2025 The core mandate of modern clinic Revenue Cycle Management (RCM) is financial stability, but the most sophisticated RCM systems in the world have a singular, catastrophic failure point: denial recovery. While traditional RCM platforms excel at the front-end, scrubbing codes and checking

Getting a denial for a high-cost rheumatology drug (like a biologic) is frustrating, but it's often reversible. Insurance companies deny a significant share of prior authorization (PA) requests, yet studies show over 80% of these initial rejections are overturned on appeal. This guide provides an accessible, step-by-step action

The word "cancer" alone brings a cascade of emotions, fear, uncertainty, and a desperate hope for effective treatment. Patients and their families steel themselves for the arduous journey ahead, ready to fight with every fiber of their being. But imagine receiving that life-altering diagnosis, only to face another,

Receiving a health insurance claim denial for your GLP-1 medication can feel like a punch to the gut. For patients who have found life-changing benefits from significant weight loss to improved metabolic health, that denial letter is more than just a piece of paper; it’s a roadblock to a